Medical properties of the drug Afluxide for gastrointestinal diseases of lamb

The aim of the study is to investigate the therapeutic properties of the drug Afluxid in gastrointestinal diseases of lambs. The paper considers the use of the drug Afluxid developed by OOO Biorost in lambs with gastrointestinal diseases at a dose of 5 g/head. 2 times a day for 3 days, which contributed to the improvement of the morphological composition of their blood, a decrease in diarrheal symptoms, a reduction in the treatment period and an increase in survival (90.0 %). In the young animals of the control group, the disease was severe and longer, and the survival rate was 80%. The content of granulocytes in the blood of lambs in the control and experimental groups was below the physiological norm by 18.4 and 25 %, respectively. At the end of the experiment, the level of granulocytes in the blood of animals of both groups did not reach physiological values. It was possibly caused by a pathological process in the body. When an inflammatory focus is formed, they begin to fight various foreign microorganisms and toxins. The initial amount of hemoglobin in the blood of lambs in the control and experimental groups was lower by 1.5 and 2.3 %, respectively, compared to the reference values. By the end of the experiment, the calcium content in the blood of lambs in the control group did not reach physiological values and amounted to 8.5 mg/%. It depends on the level of calcium in the diet, the state of the hormonal system, gastrointestinal tract, kidneys, liver and other organs. This indicates that there were no infectious or toxic effects on the animals' bodies, that the therapy provided restoration of homeostasis, and is also accompanied by an increase in some indicators in the blood of animals.